공업화학 (Applied Chemistry for Engineering)

  • 제33권5호
  • /
  • Pages.545-550
  • /
  • 2022
  • /
  • 1225-0112(pISSN)
  • /
  • 2288-4505(eISSN)
한국공업화학회 (The Korean Society of Industrial and Engineering Chemistry)
권호 표지
DOI QR코드

DOI QR Code

심장혈관용 약물코팅풍선카테터의 개발 동향

The Developing Trend of Cardiovacular Drug Coated Balloon Catheter

  • 투고 : 2022.07.08
  • 심사 : 2022.08.12
  • 발행 : 2022.10.10
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

급격한 고령화 사회로의 진입과 서구화된 식습관에 의해 협심증, 심근경색증, 고혈압 등에 의한 심장질환자의 수가 5년간 10만명 이상 증가했다. 심장질환은 지난 8년간 꾸준히 국내 사망원인 2위를 기록 중이며, 이로 인해 연간 소모되는 의료비는 6조원에 달한다. 증가한 환자와 함께 다양한 치료법이 제시되고 있는 가운데, 현재 보편화 된 관상동맥중재시술 중 스텐트 삽입술의 단점인 재협착이나 장기간 이중항혈소판제 복용으로 인한 출혈의 위험 증가 등의 문제점을 보완하기 위해 약물코팅풍선카테터가 개발되어 점차 상용화되고 있는데, 국내에선 2010년 'SeQuent PleaseⓇ (비브라운코리아)'라는 제품이 처음 출시되면서 약물코팅풍선카테터를 사용한 시술이 시작되었고, 이후 2012년 보험급여가 적용되면서 그 사용량이 본격적으로 늘어났다. 약물코팅풍선치료는 국내뿐만 아니라 전 세계적으로 사용이 증가하고 있는데, 특히 일본을 포함한 아시아태평양 지역에서 그 사용량이 급격히 증가하고 있다. 현재까지 국산 제품의 수요가 증가하고 있는 상황이며 향후, 동물시험 및 임상시험에서의 성능이 입증된다면 위험성이 높은 스텐트 삽입술에 비해 효과적인 시술이 될 것이라 예상한다.

As a result of the rapid entry into an aging society and westernized eating habits, the number of heart disease patients caused by angina pectoris, myocardial infarction, and high blood pressure has increased by more than 100,000 over five years. Heart disease has consistently ranked second in the cause of death in Korea over the past eight years, and medical expenses consumed annually reach 6 trillion won. While various treatments are being proposed for more patients, drug-coated balloon catheters have been developed and gradually commercialized to solve the disadvantages of stent implantation such as restenosis and increased risk of bleeding due to long-term double antiplatelet medication. In Korea, it began to use a drug-coated balloon catheter with the first release of it called "SeQuent PleaseⓇ (Bibrown Korea)" in 2010. Its demand increased gradually as insurance benefits were applied in 2012. Drug-coated balloon angioplasty is increasing in use not only in Korea but also around the world, especially in the Asia-Pacific region, including Japan. Until now, the demand for domestic products is increasing, and if the efficiency in vivo and clinical trials is proven in the future, it is expected to be an effective procedure compared to high-risk stent implantation.

키워드

과제정보

본 연구는 2020년 대웅재단(DY20109C), 정부(과학기술정보통신부, 산업통산자원부, 보건복지부, 식품의약품안전처)의 재원으로 범부처 전주기의료기기연구개발사업단(과제번호: RS-2020-KD000246), 2021년 전라남도와 전남테크노파크의 지역수요맞춤형 연구개발사업의 지원을 받아 수행된 연구이다.

참고문헌

  1. S. G. Raja, B, Bendetto, C. D. Ilseley, and M. Amrani, Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis, Int. J. Cardiol., 189, 153-158 (2015). https://doi.org/10.1016/j.ijcard.2015.04.059
  2. S. Kuramitsu, S. Sonoda, K. Ando, H. Otake, M. Natsuaki, R. Anai, Y. Honda, K. Kadota, Y. Kobayashi, and T. Kimura, Drug-eluting stent thrombosis: Current and future perspectives, Cardiovasc. Interv. Ther., 36, 158-168 (2021). https://doi.org/10.1007/s12928-021-00754-x
  3. J. Torrado, L. Buckley, A. Duran, P. Trujillo, S. Toldo, J. V. Raleigh, A. Abbate, G. Biondi-Zoccai, and L. A. Guzman, Restenosis, stent thrombosis, and bleeding complications: Navigating between scylla and charybdis, J. Am. Coll. Cardiol., 71, 1676-1695 (2018). https://doi.org/10.1016/j.jacc.2018.02.023
  4. R. V. Jeger, S. Eccleshall, W. A. W. Ahmad, J. Ge, T. C. Poerner, E. S. Shin, F. Alfonso, A. Latib, P. J. Ong, T. T. Rissanen, J. Saucedo, B. Scheller, and F. X. Kleber, Drug-coated balloons for coronary artery disease: Third report of the International DCB Consensus Group, JACC Cardiovasc. Interv., 13, 1391-1402 (2020). https://doi.org/10.1016/j.jcin.2020.02.043
  5. R. V. Jeger, A. A. Farah, M. A. Ohlow, N. Manger, S. Mobius-Winkler, D. Weilenmann, G. Stachel, S. Markovic, G. Leibundgut, P. Rickenbacher, S. Osswald, M. Cattaneo, N. Gilgen, C. Kaiser, and B. Scheller, Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial, Lancet, 396, 1504-1510 (2020). https://doi.org/10.1016/s0140-6736(20)32173-5
  6. R. A. Byrne, M. Joner, F. Alfonso, and A. Kastrati, Drug-coated balloon therapy in coronary and peripheral artery disease, Nat. Rev. Cardiol., 11, 13-23 (2014). https://doi.org/10.1038/nrcardio.2013.165
  7. F. X. Kleber, H. Rittger, K. Bonaventura, U. Zeymer, J. Wohrle, R. Jeger, B. Levenson, S. Mobius-Winkler, L. Bruch, D. Fischer, C. Hengstenberg, T. Porner, D. Mathey, and B. Scheller, Drug-coated balloons for treatment of coronary artery disease: Updated recommendations from a consensus group, Clin. Res. Cardiol., 102, 785-797 (2013). https://doi.org/10.1007/s00392-013-0609-7
  8. Transparency Market Research, Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026, New York, USA (2022).
  9. I. Rykowska, I. Nowak, and R. Nowak, Drug-eluting stents and balloons-materials, structure designs, and coating techniques: A review, Molecules, 25, 4624 (2020). https://doi.org/10.3390/molecules25204624
  10. S. Bose. S. S. Keller, T. S. Alstrom, A. Boisen, and K. Almdal, Process optimization of ultrasonic spray coating of polymer films, Langmuir, 29, 6911-6919 (2013). https://doi.org/10.1021/la4010246
  11. J. Ju, Y. Yamagata, and T. Higuchi, Thin-film fabrication method for organic light-emitting diodes using electrospray deposition, Adv. Mater., 21, 4343-4347 (2009). https://doi.org/10.1002/adma.200900444
  12. M. Bukka, P. J. Rednam, and M. Sinha, Drug-eluting ballon: Design, technology and clinical aspects, Biomed. Mater., 13, 032001 (2018). https://doi.org/10.1088/1748-605X/aaa0aa
  13. S. Sharma, N. Kukreja, C. Christopoulos and D. A. Gorog, Drug-eluting balloon: New tool in the box, Expert Rev. Med. Devices, 7, 381-388 (2014). https://doi.org/10.1586/erd.10.5
  14. T. Shazly, W. M. Torees, E. A. Secemsky, C. C. Chitalia, F. A. Jaffer, V. B. Kolachalam, Understudied factors in drug-coated balloon design and evaluation: A biophysical perspective, Bioeng. Transl. Med., Doi: 10.1002/btm2.10370.